FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093149504> ?p ?o ?g. }

• W2093149504 endingPage "392" @default.
• W2093149504 startingPage "375" @default.
• W2093149504 abstract "Introduction: Metastasis contributes to over 90% of cancer-related deaths. Numerous nanoparticle platforms have been developed to target and treat cancer, yet efficient delivery of these systems to the appropriate site remains challenging. Leukocytes, which share similarities to tumor cells in terms of their transport and migration through the body, are well suited to serve as carriers of drug delivery systems to target cancer sites.Areas covered: This review focuses on the use and functionalization of leukocytes for therapeutic targeting of metastatic cancer. Tumor cell and leukocyte extravasation, margination in the bloodstream, and migration into soft tissue are discussed, along with the potential to exploit these functional similarities to effectively deliver drugs. Current nanoparticle-based drug formulations for the treatment of cancer are reviewed, along with methods to functionalize delivery vehicles to leukocytes, either on the surface and/or within the cell. Recent progress in this area, both in vitro and in vivo, is also discussed, with a particular emphasis on targeting cancer cells in the bloodstream as a means to interrupt the metastatic process.Expert opinion: Leukocytes interact with cancer cells both in the bloodstream and at the site of solid tumors. These interactions can be utilized to effectively deliver drugs to targeted areas, which can reduce both the amount of drug required and various nonspecific cytotoxic effects within the body. If drug delivery vehicle functionalization does not interfere with leukocyte function, this approach may be utilized to neutralize tumor cells in the bloodstream to prevent the formation of new metastases, and also to deliver drugs to metastatic sites within tissues." @default.
• W2093149504 created "2016-06-24" @default.
• W2093149504 creator A5070201038 @default.
• W2093149504 creator A5081005464 @default.
• W2093149504 date "2014-10-01" @default.
• W2093149504 modified "2023-10-10" @default.
• W2093149504 title "Leukocytes as carriers for targeted cancer drug delivery" @default.
• W2093149504 cites W1484817497 @default.
• W2093149504 cites W1744019794 @default.
• W2093149504 cites W1859519805 @default.
• W2093149504 cites W1862647003 @default.
• W2093149504 cites W1900762885 @default.
• W2093149504 cites W195513463 @default.
• W2093149504 cites W1963349315 @default.
• W2093149504 cites W1964696475 @default.
• W2093149504 cites W1966286149 @default.
• W2093149504 cites W1968359144 @default.
• W2093149504 cites W1968583232 @default.
• W2093149504 cites W1968820371 @default.
• W2093149504 cites W1970197294 @default.
• W2093149504 cites W1978244778 @default.
• W2093149504 cites W1978273420 @default.
• W2093149504 cites W1979947689 @default.
• W2093149504 cites W1983487545 @default.
• W2093149504 cites W1983774546 @default.
• W2093149504 cites W1985614501 @default.
• W2093149504 cites W1986224320 @default.
• W2093149504 cites W1986316218 @default.
• W2093149504 cites W1987843579 @default.
• W2093149504 cites W1987848883 @default.
• W2093149504 cites W1989230986 @default.
• W2093149504 cites W1991718644 @default.
• W2093149504 cites W1997641625 @default.
• W2093149504 cites W1997771412 @default.
• W2093149504 cites W1997877282 @default.
• W2093149504 cites W1997983961 @default.
• W2093149504 cites W1998238082 @default.
• W2093149504 cites W1999733648 @default.
• W2093149504 cites W2003110090 @default.
• W2093149504 cites W2005464092 @default.
• W2093149504 cites W2006018450 @default.
• W2093149504 cites W2006611326 @default.
• W2093149504 cites W2007136227 @default.
• W2093149504 cites W2011934320 @default.
• W2093149504 cites W2012275753 @default.
• W2093149504 cites W2014713088 @default.
• W2093149504 cites W2015808599 @default.
• W2093149504 cites W2015981241 @default.
• W2093149504 cites W2020439083 @default.
• W2093149504 cites W2021249886 @default.
• W2093149504 cites W2021503270 @default.
• W2093149504 cites W2022620717 @default.
• W2093149504 cites W2027925515 @default.
• W2093149504 cites W2030054103 @default.
• W2093149504 cites W2032131088 @default.
• W2093149504 cites W2032494769 @default.
• W2093149504 cites W2032760352 @default.
• W2093149504 cites W2034255256 @default.
• W2093149504 cites W2036124306 @default.
• W2093149504 cites W2039233074 @default.
• W2093149504 cites W2041310039 @default.
• W2093149504 cites W2041401460 @default.
• W2093149504 cites W2042172082 @default.
• W2093149504 cites W2043009832 @default.
• W2093149504 cites W2043933297 @default.
• W2093149504 cites W2044001005 @default.
• W2093149504 cites W2044835625 @default.
• W2093149504 cites W2046507292 @default.
• W2093149504 cites W2046972425 @default.
• W2093149504 cites W2047782278 @default.
• W2093149504 cites W2048381378 @default.
• W2093149504 cites W2050286820 @default.
• W2093149504 cites W2052312474 @default.
• W2093149504 cites W2054745605 @default.
• W2093149504 cites W2061510929 @default.
• W2093149504 cites W2063220206 @default.
• W2093149504 cites W2064070420 @default.
• W2093149504 cites W2069172065 @default.
• W2093149504 cites W2073003323 @default.
• W2093149504 cites W2073079990 @default.
• W2093149504 cites W2073384456 @default.
• W2093149504 cites W2076532644 @default.
• W2093149504 cites W2079096224 @default.
• W2093149504 cites W2080232352 @default.
• W2093149504 cites W2080376276 @default.
• W2093149504 cites W2081531010 @default.
• W2093149504 cites W2081938664 @default.
• W2093149504 cites W2082250167 @default.
• W2093149504 cites W2082475771 @default.
• W2093149504 cites W2082908153 @default.
• W2093149504 cites W2083351034 @default.
• W2093149504 cites W2086159554 @default.
• W2093149504 cites W2087590625 @default.
• W2093149504 cites W2088223764 @default.
• W2093149504 cites W2088536552 @default.
• W2093149504 cites W2089155556 @default.
• W2093149504 cites W2089458132 @default.
• W2093149504 cites W2091637866 @default.

• next